德尔塔类阿片类受体参与多个信号级联,以差异调节前额前部GABA释放与输入和目标特异性的输入和目标特异性
Ryan P D Alexander1,2, Kevin J Bender1,2
1Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
bioRxiv : the preprint server for biology
|August 16, 2024
概括
德尔塔阿片类受体 (DORs) 调节大脑的奖励回路,没有滥用潜力. DORs通过不同的信号通路调节新皮层内部神经元中的抑制,在体和树突领域不同地影响突触传输.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 神经药理学神经药理学
背景情况:
- 阿片类药物是大脑奖励和动机电路的关键调节者.
- 德尔塔阿片类受体 (DORs) 参与奖励处理,滥用责任率低.
- DORs在新皮层内部神经元中表达,但其精确的调节机制尚不清楚.
研究的目的:
- 阐明DORs如何控制不同新皮层内部神经元群体的突触传播.
- 研究DOR激活在这些内部神经元中的特定信号通路和下游效应.
主要方法:
- 新皮层切片中的电生理学记录.
- 对DOR活性进行药理学操纵.
- 分析G蛋白信号通路和突触前通道功能.
- 评估短期的突触可塑性.
主要成果:
- DORs通过差异调节表达parvalbumin和somatostatin内部神经元的抑制.
- 独特的G蛋白信号级联由DORs参与,汇聚在前突触通道上.
- 通过DORs调节通道功能,导致分区特定的时间过效应.
- 这些效应改变了体相对树突领域的突触信息传输.
结论:
- DORs使用不同的细胞内信号机制来调节基于内部神经元类型和 postsynaptic目标区的抑制.
- 这种差异调节微调了新皮质中的突触可塑性和信息处理.
- 了解这些机制,可以了解DOR在奖励回路中的细微作用.
相关概念视频
Opioid Receptors: Overview
617
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
617
G Protein-coupled Receptors
11.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.6K
Analgesia and Pain Management
553
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
553
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K


